StonvexLoading…
StonvexStonvexStonvexCore line items from DOYU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $546.09M | $585.10M | $778.94M | $1.03B |
Operating Income | $680.14K | $-78.58M | $-23.10M | $-28.83M |
Net Income | $-29.08M | $-306.81M | $35.52M | $-75.42M |
EPS (Diluted) | $-0.14 | $-1.36 | $0.16 | $-0.34 |
Total Assets | $446.15M | $746.14M | $1.14B | $1.18B |
Total Liabilities | $161.96M | $169.36M | $194.76M | $229.78M |
Cash & Equivalents | $251.55M | $139.35M | $625.38M | $585.98M |
Free Cash Flow OCF − CapEx | $-7.51M | $-32.82M | $-7.44M | $-10.69M |
Shares Outstanding | 30.18M | 30.18M | 31.98M | 31.98M |